Ballentine Partners’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Sell
5,565
-772
-12% -$243K 0.02% 250
2026
Q1
$2.08M Buy
6,337
+955
+18% +$343K 0.03% 194
2025
Q4
$1.89M Sell
5,382
-256
-5% -$93.3K 0.03% 200
2025
Q3
$2.08M Sell
5,638
-869
-13% -$336K 0.03% 187
2025
Q2
$2.57M Sell
6,507
-1,843
-22% -$689K 0.04% 159
2025
Q1
$3.11M Sell
8,350
-18
-0.2% -$6.85K 0.05% 125
2024
Q4
$3.01M Buy
8,368
+1,327
+19% +$492K 0.05% 129
2024
Q3
$2.54M Buy
7,041
+18
+0.3% +$6.21K 0.04% 144
2024
Q2
$2.39M Sell
7,023
-16
-0.2% -$5.42K 0.04% 137
2024
Q1
$2.52M Buy
7,039
+181
+3% +$60.9K 0.05% 130
2023
Q4
$2.05M Buy
6,858
+1,070
+18% +$300K 0.04% 140
2023
Q3
$1.58M Buy
5,788
+49
+0.9% +$14.1K 0.04% 143
2023
Q2
$1.75M Sell
5,739
-413
-7% -$119K 0.04% 133
2023
Q1
$1.76M Buy
6,152
+717
+13% +$190K 0.04% 136
2022
Q4
$1.33M Buy
5,435
+24
+0.4% +$5.45K 0.04% 142
2022
Q3
$1.1M Buy
5,411
+108
+2% +$22.7K 0.04% 147
2022
Q2
$1.05M Sell
5,303
-23
-0.4% -$5.4K 0.04% 150
2022
Q1
$1.42M Buy
5,326
+159
+3% +$41.1K 0.04% 138
2021
Q4
$1.38M Buy
5,167
+1,310
+34% +$344K 0.04% 145
2021
Q3
$1.02M Buy
3,857
+12
+0.3% +$3.21K 0.03% 156
2021
Q2
$1M Sell
3,845
-241
-6% -$61.6K 0.03% 153
2021
Q1
$994K Sell
4,086
-116
-3% -$27.8K 0.04% 153
2020
Q4
$1.03M Sell
4,202
-352
-8% -$79.7K 0.04% 143
2020
Q3
$949K Buy
4,554
+22
+0.5% +$4.28K 0.04% 148
2020
Q2
$816K Buy
4,532
+27
+0.6% +$4.98K 0.04% 157
2020
Q1
$749K Buy
4,505
+60
+1% +$11.7K 0.04% 148
2019
Q4
$933K Sell
4,445
-84
-2% -$17.4K 0.04% 161
2019
Q3
$980K Sell
4,529
-25
-0.5% -$5.36K 0.05% 148
2019
Q2
$935K Buy
4,554
+347
+8% +$66.3K 0.04% 155
2019
Q1
$832K Buy
4,207
+27
+0.6% +$4.86K 0.04% 148
2018
Q4
$656K Buy
4,180
+54
+1% +$9.03K 0.04% 163
2018
Q3
$734K Buy
4,126
+37
+0.9% +$6.32K 0.04% 159
2018
Q2
$691K Buy
4,089
+15
+0.4% +$2.52K 0.04% 156
2018
Q1
$656K Buy
4,074
+47
+1% +$7.58K 0.04% 157
2017
Q4
$623K Sell
4,027
-73
-2% -$11.1K 0.03% 165
2017
Q3
$581K Sell
4,100
-134
-3% -$19.2K 0.03% 176
2017
Q2
$616K Buy
4,234
+1,115
+36% +$153K 0.05% 170
2017
Q1
$410K Sell
3,119
-1,673
-35% -$211K 0.03% 142
2016
Q4
$573K Buy
4,792
+87
+2% +$10K 0.04% 95
2016
Q3
$547K Sell
4,705
-23
-0.5% -$2.68K 0.04% 90
2016
Q2
$567K Sell
4,728
-3
-0.1% -$335 0.05% 95
2016
Q1
$506K Sell
4,731
-334
-7% -$32.9K 0.04% 106
2015
Q4
$471K Buy
5,065
+46
+0.9% +$4.4K 0.05% 103
2015
Q3
$472K Buy
5,019
+35
+0.7% +$3.47K 0.05% 93
2015
Q2
$476K Hold
4,984
0.05% 95
2015
Q1
$460K Buy
4,984
+166
+3% +$15.5K 0.05% 96
2014
Q4
$455K Hold
4,818
0.05% 94
2014
Q3
$389K Buy
4,818
+13
+0.3% +$1.07K 0.05% 99
2014
Q2
$405K Sell
4,805
-38
-0.8% -$3.1K 0.05% 94
2014
Q1
$395K Sell
4,843
-520
-10% -$41.4K 0.05% 93
2013
Q4
$403K Hold
5,363
0.05% 97
2013
Q3
$363K Buy
5,363
+300
+6% +$20.7K 0.04% 100
2013
Q2
$327K Buy
+5,063
New +$336K 0.04% 85

Other funds holding SYK

Ballentine Partners's SYK Position: Q2 2026 in Review

Ballentine Partners reduced its Stryker (SYK) stake by 12% in Q2 2026, selling an estimated $243K and leaving 5,565 shares worth $1.75M. The position accounts for 0.02% of the portfolio, ranked #250.

Ballentine Partners first reported a position in SYK in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.11M in Q1 2025. 402 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Ballentine Partners held 5,565 shares of Stryker worth $1.75M as of Q2 2026.
  • Ballentine Partners sold 772 Stryker shares in Q2 2026, an estimated $243K.
  • Stryker made up 0.02% of Ballentine Partners's portfolio in Q2 2026, its #250 holding.
  • Ballentine Partners first reported a position in Stryker in Q2 2013 and has held it in 53 quarters since.
  • Ballentine Partners's Stryker position peaked at $3.11M in Q1 2025.
  • 402 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.